These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28672144)

  • 1. Zn(II) - pramlintide: Stability, binding sites and unexpected aggregation.
    Łoboda D; Rowińska-Żyrek M
    J Inorg Biochem; 2017 Sep; 174():150-155. PubMed ID: 28672144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination of Zn(2+) and Cu(2+) to the membrane disrupting fragment of amylin.
    Rowińska-Żyrek M
    Dalton Trans; 2016 May; 45(19):8099-106. PubMed ID: 27086774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidogenesis of the amylin analogue pramlintide.
    da Silva DC; Fontes GN; Erthal LC; Lima LM
    Biophys Chem; 2016 Dec; 219():1-8. PubMed ID: 27665170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight into a New Binding Site of Zinc Ions in Fibrillar Amylin.
    Wineman-Fisher V; Miller Y
    ACS Chem Neurosci; 2017 Sep; 8(9):2078-2087. PubMed ID: 28692245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II) and Amylin Analogues: A Complicated Relationship.
    Alghrably M; Dudek D; Emwas AH; Jaremko Ł; Jaremko M; Rowińska-Żyrek M
    Inorg Chem; 2020 Feb; 59(4):2527-2535. PubMed ID: 32027132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zn(II) binding to pramlintide results in a structural kink, fibril formation and antifungal activity.
    Dudek D; Dzień E; Wątły J; Matera-Witkiewicz A; Mikołajczyk A; Hajda A; Olesiak-Bańska J; Rowińska-Żyrek M
    Sci Rep; 2022 Nov; 12(1):20543. PubMed ID: 36446825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Full length amylin oligomer aggregation: insights from molecular dynamics simulations and implications for design of aggregation inhibitors.
    Berhanu WM; Masunov AE
    J Biomol Struct Dyn; 2014; 32(10):1651-69. PubMed ID: 24028418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
    da Silva DC; Lima LMTR
    Int J Pharm; 2018 Aug; 547(1-2):621-629. PubMed ID: 29928940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete characterization of the mutation landscape reveals the effect on amylin stability and amyloidogenicity.
    Smaoui MR; Waldispühl J
    Proteins; 2015 Jun; 83(6):1014-26. PubMed ID: 25809921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the binding affinity of amyloids to reduce toxicity of oligomers in diabetes.
    Smaoui MR; Orland H; Waldispühl J
    Bioinformatics; 2015 Jul; 31(14):2294-302. PubMed ID: 25777526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the ability of pramlintide to inhibit amyloid formation by human islet amyloid polypeptide reveals a balance between optimal recognition and reduced amyloidogenicity.
    Wang H; Ridgway Z; Cao P; Ruzsicska B; Raleigh DP
    Biochemistry; 2015 Nov; 54(44):6704-11. PubMed ID: 26407043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH dependence of amylin fibrillization.
    Jha S; Snell JM; Sheftic SR; Patil SM; Daniels SB; Kolling FW; Alexandrescu AT
    Biochemistry; 2014 Jan; 53(2):300-10. PubMed ID: 24377660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
    Gingell JJ; Burns ER; Hay DL
    Endocrinology; 2014 Jan; 155(1):21-6. PubMed ID: 24169554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Be positive: optimizing pramlintide from microcanonical analysis of amylin isoforms.
    Frigori RB
    Phys Chem Chem Phys; 2017 Sep; 19(37):25617-25633. PubMed ID: 28905065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the assembly and amyloid aggregation of murine amylin by zinc.
    Erthal LC; Marques AF; Almeida FC; Melo GL; Carvalho CM; Palmieri LC; Cabral KM; Fontes GN; Lima LM
    Biophys Chem; 2016 Nov; 218():58-70. PubMed ID: 27693831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme.
    Bellia F; Grasso G
    J Mass Spectrom; 2014 Apr; 49(4):274-9. PubMed ID: 24719342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc Interactions with a Soluble Mutated Rat Amylin to Mimic Whole Human Amylin: An Experimental and Simulation Approach to Understand Stoichiometry, Speciation and Coordination of the Metal Complexes.
    Magrì A; Tabbì G; Di Natale G; La Mendola D; Pietropaolo A; Zoroddu MA; Peana M; Rizzarelli E
    Chemistry; 2020 Oct; 26(57):13072-13084. PubMed ID: 32488947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Zn(2+) ions on the assembly of amylin oligomers: insight into the molecular mechanisms.
    Wineman-Fisher V; Miller Y
    Phys Chem Chem Phys; 2016 Aug; 18(31):21590-9. PubMed ID: 27425207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.
    Li H; Ha E; Donaldson RP; Jeremic AM; Vertes A
    Anal Chem; 2015 Oct; 87(19):9829-9837. PubMed ID: 26352401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus.
    Jeong HR; An SS
    Clin Interv Aging; 2015; 10():1873-9. PubMed ID: 26604727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.